Shares of Lannett Co Inc (NYSE:LCI) hit a new 52-week low on Friday . The stock traded as low as $16.00 and last traded at $16.08, with a volume of 361,432 shares. The stock had previously closed at $16.15.

Several analysts recently weighed in on the stock. Zacks Investment Research cut shares of Lannett Co from a “buy” rating to a “hold” rating in a research note on Thursday, May 4th. Oppenheimer Holdings, Inc. reissued a “hold” rating on shares of Lannett Co in a research note on Tuesday, May 2nd. BidaskClub cut shares of Lannett Co from a “sell” rating to a “strong sell” rating in a research note on Tuesday. Robert W. Baird reissued an “outperform” rating and issued a $18.00 price objective on shares of Lannett Co in a research note on Wednesday, May 3rd. Finally, Roth Capital set a $27.00 price objective on shares of Lannett Co and gave the stock a “buy” rating in a research note on Tuesday, May 2nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the stock. Lannett Co has a consensus rating of “Hold” and an average price target of $27.50.

The stock’s market cap is $597.54 million. The company’s 50 day moving average price is $20.12 and its 200 day moving average price is $21.31.

A number of large investors have recently made changes to their positions in LCI. Capital Fund Management S.A. raised its stake in shares of Lannett Co by 80.2% in the first quarter. Capital Fund Management S.A. now owns 56,677 shares of the company’s stock worth $1,267,000 after buying an additional 25,219 shares during the period. State Board of Administration of Florida Retirement System raised its stake in shares of Lannett Co by 167.5% in the first quarter. State Board of Administration of Florida Retirement System now owns 83,975 shares of the company’s stock worth $1,877,000 after buying an additional 52,580 shares during the period. Chicago Equity Partners LLC purchased a new stake in shares of Lannett Co during the first quarter worth about $1,536,000. LSV Asset Management raised its stake in shares of Lannett Co by 13.6% in the first quarter. LSV Asset Management now owns 1,691,935 shares of the company’s stock worth $37,814,000 after buying an additional 202,878 shares during the period. Finally, Heartland Advisors Inc. purchased a new stake in shares of Lannett Co during the first quarter worth about $11,175,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “Lannett Co Inc (NYSE:LCI) Sets New 52-Week Low at $16.00” was posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.watchlistnews.com/lannett-co-inc-nyselci-sets-new-52-week-low-at-16-00/1473582.html.

Lannett Co Company Profile

Lannett Company, Inc develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The Company manufactures and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.

Receive News & Ratings for Lannett Co Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett Co Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.